Peter C. Richardson
EVP Chief Scientific Officer · Keenova Therapeutics plc
- 2025
- Jul 31, 2025
- 1
Summary
Latest filing:
Peter C. Richardson has 1 SEC Form 4 filing on record, dated 31 July 2025.
Trading pattern
InsiderAlpha's records for Peter C. Richardson go back to 2025: 1 primary Form 4 filing, an average of 0.5 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
Most active insiders across the market
Peter C. Richardson has no co-filers on record, so these are insiders with the largest open-market activity across the market in the last 90 days.
- Magnetar Financial LLC - $1.47B in CRWV purchases and sales in the last 90 days
- CASCADE INVESTMENT, L.L.C. - $1.38B in RSG purchases and sales in the last 90 days
- GIC Private Ltd - $1.15B in MDLN purchases and sales in the last 90 days
- James Michael Chu - $1.10B in BIRK purchases and sales in the last 90 days
- Mark A. Stevens - $946.63M in NVDA purchases and sales in the last 90 days
- Angeliki Frangou - $847.74M in NMM purchases and sales in the last 90 days
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Peter C. Richardson?
Peter C. Richardson is a corporate insider, tracked as EVP Chief Scientific Officer. InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Peter C. Richardson last file a Form 4?
The only primary Form 4 on record is dated 31 July 2025.
Learn more
No Form 4 transactions on record for Peter C. Richardson yet.
Filings appear here automatically as they arrive from SEC EDGAR.